Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 30

1.

Antipsychotic-induced sensitization and tolerance: Behavioral characteristics, developmental impacts, and neurobiological mechanisms.

Li M.

J Psychopharmacol. 2016 Aug;30(8):749-70. doi: 10.1177/0269881116654697. Epub 2016 Jul 1. Review.

2.

Effects of Cannabis sativa extract on haloperidol-induced catalepsy and oxidative stress in the mice.

Abdel-Salam OM, El-Sayed El-Shamarka M, Salem NA, El-Din M Gaafar A.

EXCLI J. 2012 Feb 24;11:45-58. eCollection 2012.

3.

2-Bromoterguride-a potential atypical antipsychotic drug without metabolic effects in rats.

Franke RT, Tarland E, Fink H, Pertz HH, Brosda J.

Psychopharmacology (Berl). 2016 Aug;233(15-16):3041-50. doi: 10.1007/s00213-016-4356-0. Epub 2016 Jun 17.

4.

Y-QA31, a novel dopamine D3 receptor antagonist, exhibits antipsychotic-like properties in preclinical animal models of schizophrenia.

Sun X, Gou HY, Li F, Lu GY, Song R, Yang RF, Wu N, Su RB, Cong B, Li J.

Acta Pharmacol Sin. 2016 Mar;37(3):322-33. doi: 10.1038/aps.2015.105. Epub 2016 Jan 18.

5.

Reversal of social deficits by subchronic oxytocin in two autism mouse models.

Teng BL, Nikolova VD, Riddick NV, Agster KL, Crowley JJ, Baker LK, Koller BH, Pedersen CA, Jarstfer MB, Moy SS.

Neuropharmacology. 2016 Jun;105:61-71. doi: 10.1016/j.neuropharm.2015.12.025. Epub 2015 Dec 31.

6.

Effects of repeated quetiapine treatment on conditioned avoidance responding in rats.

Gao J, Feng M, Swalve N, Davis C, Sui N, Li M.

Eur J Pharmacol. 2015 Dec 15;769:154-61. doi: 10.1016/j.ejphar.2015.11.011. Epub 2015 Nov 14.

PMID:
26586334
7.

Adolescent olanzapine sensitization is correlated with hippocampal stem cell proliferation in a maternal immune activation rat model of schizophrenia.

Chou S, Jones S, Li M.

Brain Res. 2015 Aug 27;1618:122-35. doi: 10.1016/j.brainres.2015.05.036. Epub 2015 Jun 3.

8.

Effects of central activation of serotonin 5-HT2A/2C or dopamine D 2/3 receptors on the acute and repeated effects of clozapine in the conditioned avoidance response test.

Feng M, Gao J, Sui N, Li M.

Psychopharmacology (Berl). 2015 Apr;232(7):1219-30. doi: 10.1007/s00213-014-3756-2. Epub 2014 Oct 7.

9.

Functional profile of a novel modulator of serotonin, dopamine, and glutamate neurotransmission.

Snyder GL, Vanover KE, Zhu H, Miller DB, O'Callaghan JP, Tomesch J, Li P, Zhang Q, Krishnan V, Hendrick JP, Nestler EJ, Davis RE, Wennogle LP, Mates S.

Psychopharmacology (Berl). 2015 Feb;232(3):605-21. doi: 10.1007/s00213-014-3704-1. Epub 2014 Aug 15.

10.

Differential effects of intermittent versus continuous haloperidol treatment throughout adolescence on haloperidol sensitization and social behavior in adulthood.

Gao J, Li M.

Prog Neuropsychopharmacol Biol Psychiatry. 2014 Oct 3;54:67-75. doi: 10.1016/j.pnpbp.2014.05.015. Epub 2014 Jun 3.

11.

Desipramine enhances the ability of risperidone to decrease alcohol intake in the Syrian golden hamster.

Gulick D, Chau DT, Khokhar JY, Dawson R, Green AI.

Psychiatry Res. 2014 Aug 30;218(3):329-34. doi: 10.1016/j.psychres.2014.04.038. Epub 2014 May 4.

12.

Long-lasting sensitization induced by repeated risperidone treatment in adolescent Sprague-Dawley rats: a possible D2 receptor mediated phenomenon?

Qiao J, Gao J, Shu Q, Zhang Q, Hu G, Li M.

Psychopharmacology (Berl). 2014 Apr;231(8):1649-59. doi: 10.1007/s00213-013-3386-0. Epub 2013 Dec 21.

13.

Time-dependence of risperidone and asenapine sensitization and associated D2 receptor mechanism.

Gao J, Li M.

Behav Brain Res. 2013 Nov 15;257:286-94. doi: 10.1016/j.bbr.2013.09.050. Epub 2013 Oct 5.

14.

Serotonin2C Receptors and the Motor Control of Oral Activity.

Lagière M, Navailles S, Bosc M, Guthrie M, Deurwaerdère PD.

Curr Neuropharmacol. 2013 Mar;11(2):160-70. doi: 10.2174/1570159X11311020003.

15.

The muscarinic acetylcholine receptor agonist BuTAC mediates antipsychotic-like effects via the M4 subtype.

Watt ML, Rorick-Kehn L, Shaw DB, Knitowski KM, Quets AT, Chesterfield AK, McKinzie DL, Felder CC.

Neuropsychopharmacology. 2013 Dec;38(13):2717-26. doi: 10.1038/npp.2013.186. Epub 2013 Aug 2.

16.

Second-generation antipsychotics cause a rapid switch to fat oxidation that is required for survival in C57BL/6J mice.

Klingerman CM, Stipanovic ME, Bader M, Lynch CJ.

Schizophr Bull. 2014 Mar;40(2):327-40. doi: 10.1093/schbul/sbs196. Epub 2013 Jan 17.

17.

Avoidance disruptive effect of clozapine and olanzapine is potentiated by increasing the test trials: further test of the motivational salience hypothesis.

Feng M, Sui N, Li M.

Pharmacol Biochem Behav. 2013 Jan;103(3):467-73. doi: 10.1016/j.pbb.2012.09.013. Epub 2012 Sep 28.

18.

Prior haloperidol, but not olanzapine, exposure augments the pursuit of reward cues: implications for substance abuse in schizophrenia.

Bédard AM, Maheux J, Lévesque D, Samaha AN.

Schizophr Bull. 2013 May;39(3):692-702. doi: 10.1093/schbul/sbs077. Epub 2012 Aug 27.

19.
20.

Evaluation of the behavioral and pharmacokinetic profile of SYA013, a homopiperazine analog of haloperidol in rats.

Bricker B, Jackson T, Boateng B, Zhu XY, Ablordeppey SY.

Pharmacol Biochem Behav. 2012 Aug;102(2):294-301. doi: 10.1016/j.pbb.2012.05.003. Epub 2012 May 12.

Items per page

Supplemental Content

Write to the Help Desk